Cart
sales@molnova.com
PI3K-IN-38
CAS No. 1382979-64-7
PI3K-IN-38( —— )
Catalog No. M35576 CAS No. 1382979-64-7
PI3K-IN-38 is an orally available and potent PI3K inhibitor with an IC50 value of 0.541 μM for PI3K-α. PI3K-IN-38 exhibits anticancer and anti-inflammatory activity and inhibits tumor growth in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 172 | In Stock |
|
| 10MG | 254 | In Stock |
|
| 25MG | 392 | In Stock |
|
| 50MG | 531 | In Stock |
|
| 100MG | 710 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePI3K-IN-38
-
NoteResearch use only, not for human use.
-
Brief DescriptionPI3K-IN-38 is an orally available and potent PI3K inhibitor with an IC50 value of 0.541 μM for PI3K-α. PI3K-IN-38 exhibits anticancer and anti-inflammatory activity and inhibits tumor growth in vivo.
-
DescriptionPI3K-IN-38 (compound 123) is an orally active PI3K inhibitor with IC50 of 0.541 μM (PI3K-α). PI3K-IN-38 shows activities of anticancer and anti-inflammatory, which inhibis tumor growth in vivo.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3K
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1382979-64-7
-
Formula Weight380.44
-
Molecular FormulaC20H24N6O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1(C)C2=NC=3C(N2CCO1)=NC(=NC3N4CCOCC4)C5=CC=C(N)C=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dotson J, et al. Tricyclic pi3k inhibitor compounds and methods of use. WO2012082997A1.
molnova catalog
related products
-
Idelalisib (b)
Idelalisib is a selective inhibitor of p110δ(IC50 : 2.5 nM; in cell-free assays); shown to have 40- to 300-fold greater selectivity for p110δ than p110α/β/γ, and 400- to 4000-fold more selectivity to p110δ than C2β, hVPS34, DNA-PK and mTOR.
-
Duvelisib
A potent, selective PI3Kδ/γ inhibitor with Ki of 23 pM/243 pM, IC50 of 1 nM/50 nM.
-
GNE-477
A potent, dual PI3K/mTOR inhibitor with IC50 of 4 nM for PI3Kα, Ki of 21 nM for mTOR.
